CCMG statement on gene patents

Clinical Genetics

Volumn 82, Issue 5, 2012, Pages 405-407

  Richer, J ^a   Nelson, T N ^b   Evans, J ^c   Armstrong, L ^b   Lauzon, J ^d   McGillivray, B ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Ethics; Human genome; Licensing; Patents

Indexed keywords

CANADA; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; COVALENT BOND; DNA SEQUENCE; GENE AMPLIFICATION; GENE REPLICATION; GENETIC VARIABILITY; HUMAN; HUMAN GENETICS; HUMAN GENOME; HYDROGEN BOND; MEDICAL GENETICS; NOTE; PATENT; PRIORITY JOURNAL; REPRODUCIBILITY; RNA SEQUENCE;

CANADA; GENETIC TESTING; HUMANS; PATENTS AS TOPIC; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA;

EID: 84867586448     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12009     Document Type: Note

References (0)